Craig C. Hopkinson
EVP R&D, Chief Medical Officer · 11 filings · Latest: Aug 3, 2026
Alkermes plc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Aug 3, 2026 | Sale | $48.58 | 9,000 | $437.2K | 69,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Aug 3, 2026 | Option Exercise | $24.48 | 5,000 | $122.4K | 78,389 | |
ALKS | Hopkinson Craig C. | — | Aug 3, 2026 | Proposed Sale | $48.58 | 9,000 | $437.2K | — | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jul 1, 2026 | Sale | $51.51 | 9,000 | $463.6K | 73,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jul 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 82,389 | |
ALKS | Hopkinson Craig C. | — | Jul 1, 2026 | Proposed Sale | $51.51 | 9,000 | $463.6K | — | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 1, 2026 | Sale | $41.67 | 9,000 | $375.0K | 77,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Jun 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 86,389 | |
ALKS | Hopkinson Craig C. | — | Jun 1, 2026 | Proposed Sale | $41.67 | 9,000 | $375.0K | — | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | May 1, 2026 | Sale | $33.40 | 9,000 | $300.6K | 81,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | May 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 90,389 | |
ALKS | Hopkinson Craig C. | — | May 1, 2026 | Proposed Sale | $33.40 | 9,000 | $300.6K | — | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Apr 1, 2026 | Sale | $35.51 | 9,000 | $319.6K | 85,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Apr 1, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 94,389 | |
ALKS | Hopkinson Craig C. | — | Apr 1, 2026 | Proposed Sale | $35.51 | 9,000 | $319.6K | — | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Mar 2, 2026 | Sale | $29.72 | 9,000 | $267.5K | 89,389 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Mar 2, 2026 | Option Exercise | $19.34 | 5,000 | $96.7K | 98,389 | |
ALKS | Hopkinson Craig C. | — | Mar 2, 2026 | Proposed Sale | $29.72 | 9,000 | $267.5K | — | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 26, 2026 | Option Exercise | — | 6,866 | — | 96,438 | |
ALKS | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Feb 23, 2026 | Option Exercise | — | 7,689 | — | 92,986 |
Page 1 of 2
Next →